PMC:7060195 / 5298-7874
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
152 | 1433-1464 | Gene | denotes | angiotensin-converting enzyme 2 | Gene:59272 |
153 | 1466-1470 | Gene | denotes | ACE2 | Gene:59272 |
154 | 754-755 | Gene | denotes | S | Gene:43740568 |
155 | 688-689 | Gene | denotes | S | Gene:43740568 |
156 | 73-84 | Species | denotes | coronavirus | Tax:11118 |
157 | 193-197 | Species | denotes | CoVs | Tax:11118 |
158 | 262-270 | Species | denotes | SARS-CoV | Tax:694009 |
159 | 274-282 | Species | denotes | MERS-CoV | Tax:1335626 |
160 | 429-437 | Species | denotes | SARS-CoV | Tax:694009 |
161 | 481-484 | Species | denotes | CoV | Tax:11118 |
162 | 607-617 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
163 | 693-703 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
164 | 777-787 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
165 | 903-913 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
166 | 963-972 | Species | denotes | SARS-CoVs | Tax:694009 |
167 | 1272-1289 | Species | denotes | influenza A virus | Tax:11320 |
168 | 1502-1511 | Species | denotes | 2019-nCoV | Tax:2697049 |
169 | 1551-1556 | Species | denotes | human | Tax:9606 |
170 | 1557-1566 | Species | denotes | SARS-CoVs | Tax:694009 |
171 | 2039-2048 | Species | denotes | SARS-CoVs | Tax:694009 |
172 | 2098-2119 | Species | denotes | African green monkeys | Tax:9534 |
173 | 2154-2162 | Species | denotes | SARS-CoV | Tax:694009 |
174 | 2207-2215 | Species | denotes | SARS-CoV | Tax:694009 |
175 | 2245-2253 | Species | denotes | SARS-CoV | Tax:694009 |
176 | 2438-2448 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
177 | 1152-1161 | Species | denotes | influenza | Tax:11320 |
178 | 649-658 | Disease | denotes | infection | MESH:D007239 |
179 | 1841-1856 | Disease | denotes | viral infection | MESH:D001102 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T16 | 12-20 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T17 | 96-103 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T18 | 127-130 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T19 | 158-165 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T20 | 300-307 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T21 | 348-355 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T22 | 401-408 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T23 | 409-412 | Body_part | denotes | DNA | http://purl.org/sig/ont/fma/fma74412 |
T24 | 466-473 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T25 | 596-603 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T26 | 675-687 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
T27 | 766-773 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T28 | 871-878 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T29 | 1011-1018 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T30 | 1104-1114 | Body_part | denotes | Antibodies | http://purl.org/sig/ont/fma/fma62871 |
T31 | 1410-1415 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T32 | 1491-1498 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T33 | 1604-1615 | Body_part | denotes | amino acids | http://purl.org/sig/ont/fma/fma82739 |
T34 | 1930-1937 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T35 | 1966-1974 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T36 | 2143-2150 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T37 | 2258-2266 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid_AGAC
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
p10963s4 | 166-175 | NegReg | denotes | abrogated |
p10963s6 | 180-189 | MPA | denotes | virulence |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T29 | 262-270 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T30 | 429-437 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T31 | 607-615 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T32 | 693-701 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T33 | 777-785 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T34 | 903-911 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T35 | 963-967 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T36 | 1152-1161 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T37 | 1272-1281 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T38 | 1557-1561 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T39 | 1841-1856 | Disease | denotes | viral infection | http://purl.obolibrary.org/obo/MONDO_0005108 |
T40 | 1847-1856 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T41 | 1867-1871 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T42 | 2039-2043 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T43 | 2154-2162 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T44 | 2207-2215 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T45 | 2245-2253 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T46 | 2438-2446 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T35 | 71-72 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T36 | 288-289 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T37 | 517-518 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T38 | 723-728 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T39 | 824-826 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T40 | 832-834 | http://purl.obolibrary.org/obo/CLO_0001627 | denotes | aa |
T41 | 840-842 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T42 | 840-842 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T43 | 848-850 | http://purl.obolibrary.org/obo/CLO_0001627 | denotes | aa |
T44 | 868-870 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T45 | 868-870 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T46 | 914-921 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
T47 | 959-962 | http://purl.obolibrary.org/obo/NCBITaxon_9397 | denotes | bat |
T48 | 1008-1010 | http://purl.obolibrary.org/obo/CLO_0008922 | denotes | S2 |
T49 | 1008-1010 | http://purl.obolibrary.org/obo/CLO_0050052 | denotes | S2 |
T50 | 1078-1085 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T51 | 1089-1095 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
T52 | 1282-1283 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T53 | 1310-1312 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T54 | 1383-1388 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T55 | 1410-1415 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T56 | 1488-1490 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T57 | 1551-1556 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T58 | 1721-1726 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T59 | 1781-1782 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T60 | 1783-1788 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T61 | 1804-1805 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T62 | 2000-2001 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T63 | 2112-2119 | http://purl.obolibrary.org/obo/NCBITaxon_9479 | denotes | monkeys |
T64 | 2172-2179 | http://purl.obolibrary.org/obo/NCBITaxon_9479 | denotes | monkeys |
T65 | 2358-2364 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
T66 | 2424-2426 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
T67 | 2517-2523 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T17 | 12-20 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T18 | 96-103 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T19 | 158-165 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T20 | 300-307 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T21 | 348-355 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T22 | 401-408 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T23 | 409-412 | Chemical | denotes | DNA | http://purl.obolibrary.org/obo/CHEBI_16991 |
T24 | 466-473 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T25 | 596-603 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T26 | 675-687 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
T27 | 766-773 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T28 | 840-842 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T29 | 868-870 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T30 | 871-878 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T31 | 1008-1010 | Chemical | denotes | S2 | http://purl.obolibrary.org/obo/CHEBI_29387 |
T32 | 1011-1018 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T33 | 1048-1057 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T34 | 1433-1444 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T35 | 1491-1498 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T36 | 1604-1615 | Chemical | denotes | amino acids | http://purl.obolibrary.org/obo/CHEBI_33709 |
T37 | 1604-1609 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T38 | 1610-1615 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
T39 | 1930-1937 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T40 | 2143-2150 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T41 | 2258-2266 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T8 | 53-67 | http://purl.obolibrary.org/obo/GO_0019068 | denotes | viral assembly |
T9 | 180-189 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | virulence |
T10 | 180-189 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | virulence |
T11 | 372-387 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
T12 | 1841-1856 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infection |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T37 | 0-143 | Sentence | denotes | The E and M proteins have important functions in the viral assembly of a coronavirus, and the N protein is necessary for viral RNA synthesis13. |
T38 | 144-341 | Sentence | denotes | Deletion of E protein abrogated the virulence of CoVs, and several studies have explored the potential of recombinant SARS-CoV or MERS-CoV with a mutated E protein as live attenuated vaccines13,14. |
T39 | 342-661 | Sentence | denotes | The M protein can augment the immune response induced by N protein DNA vaccine against SARS-CoV;15 however, the conserved N protein across CoV families implies that it is not a suitable candidate for vaccine development, and the antibodies against the N protein of SARS-CoV-2 do not provide immunity to the infection16. |
T40 | 662-749 | Sentence | denotes | The critical glycoprotein S of SARS-CoV-2 is responsible for virus binding and entry16. |
T41 | 750-863 | Sentence | denotes | The S precursor protein of SARS-CoV-2 can be proteolytically cleaved into S1 (685 aa) and S2 (588 aa) subunits10. |
T42 | 864-975 | Sentence | denotes | The S2 protein is well conserved among SARS-CoV-2 viruses and shares 99% identity with that of bat SARS-CoVs10. |
T43 | 976-1103 | Sentence | denotes | The vaccine design based on the S2 protein may boost the broad-spectrum antiviral effect and is worth testing in animal models. |
T44 | 1104-1292 | Sentence | denotes | Antibodies against the conserved stem region of influenza hemagglutinin have been found to exhibit broadly cross-reactive immunity, but are less potent in neutralizing influenza A virus17. |
T45 | 1293-1483 | Sentence | denotes | In contrast, the S1 subunit consists of the receptor-binding domain (RBD), which mediates virus entry into sensitive cells through the host angiotensin-converting enzyme 2 (ACE2) receptor18. |
T46 | 1484-1567 | Sentence | denotes | The S1 protein of 2019-nCoV shares about 70% identity with that of human SARS-CoVs. |
T47 | 1568-1750 | Sentence | denotes | The highest number of variations of amino acids in the RBD is located in the external subdomain, which is responsible for the direct interaction between virus and host receptor10,18. |
T48 | 1751-1857 | Sentence | denotes | Blocking the initial entry of a virus is proposed as a successful strategy in controlling viral infection. |
T49 | 1858-2051 | Sentence | denotes | Based on SARS vaccine development, most vaccine candidates target the S protein, which induces neutralizing antibody responses and stimulates a protective cellular immunity against SARS-CoVs12. |
T50 | 2052-2226 | Sentence | denotes | Bukreyev et al.19 showed that immunization of African green monkeys with the full-length S protein of SARS-CoV protects monkeys from subsequent homologous SARS-CoV challenge. |
T51 | 2227-2374 | Sentence | denotes | Administration of SARS-CoV RBD proteins can also induce highly potent neutralizing antibodies and long-term protective immunity in animal models20. |
T52 | 2375-2576 | Sentence | denotes | Thus, the generation of antibodies targeting the S1 subunit of SARS-CoV-2 would be an important preventive and treatment strategy that can be tested further in suitable models before clinical trials10. |